BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 31981592)

  • 1. SET domain-containing 5 is a potential prognostic biomarker that promotes esophageal squamous cell carcinoma stemness.
    Piao L; Li H; Feng Y; Yang Z; Kim S; Xuan Y
    Exp Cell Res; 2020 Apr; 389(1):111861. PubMed ID: 31981592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B7H4 is associated with stemness and cancer progression in esophageal squamous cell carcinoma.
    Piao L; Yang Z; Jin J; Ni W; Qi W; Xuan Y
    Hum Pathol; 2018 Oct; 80():152-162. PubMed ID: 29885401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tenascin-C is involved in promotion of cancer stemness via the Akt/HIF1ɑ axis in esophageal squamous cell carcinoma.
    Yang Z; Zhang C; Feng Y; Qi W; Cui Y; Xuan Y
    Exp Mol Pathol; 2019 Aug; 109():104239. PubMed ID: 30904401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Musashi1, a potential prognostic marker in esophageal squamous cell carcinoma.
    Qin G; Lian J; Yue D; Chen X; Nan S; Qi Y; Li B; Cui G; Li X; Zhao S; Zhang Y
    Oncol Rep; 2017 Sep; 38(3):1724-1732. PubMed ID: 28713964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
    Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
    Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
    Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
    Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
    [No Abstract]   [Full Text] [Related]  

  • 7. Epigenetic induction of tumor stemness via the lipopolysaccharide-TET3-HOXB2 signaling axis in esophageal squamous cell carcinoma.
    Xu F; Liu Z; Liu R; Lu C; Wang L; Mao W; Zhu Q; Shou H; Zhang K; Li Y; Chu Y; Gu J; Ge D
    Cell Commun Signal; 2020 Feb; 18(1):17. PubMed ID: 32014008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of LETM1 as a marker of cancer stem-like cells and predictor of poor prognosis in esophageal squamous cell carcinoma.
    Yang Z; Ni W; Cui C; Qi W; Piao L; Xuan Y
    Hum Pathol; 2018 Nov; 81():148-156. PubMed ID: 30031102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.
    Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J
    J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gli1, a potential regulator of esophageal cancer stem cell, is identified as an independent adverse prognostic factor in esophageal squamous cell carcinoma.
    Yang Z; Cui Y; Ni W; Kim S; Xuan Y
    J Cancer Res Clin Oncol; 2017 Feb; 143(2):243-254. PubMed ID: 27680978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tex10 promotes stemness and EMT phenotypes in esophageal squamous cell carcinoma via the Wnt/β‑catenin pathway.
    Xiang X; Xiong R; Yu C; Deng L; Bie J; Xiao D; Chen Z; Zhou Y; Li X; Liu K; Feng G
    Oncol Rep; 2019 Dec; 42(6):2600-2610. PubMed ID: 31638260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of AAA-domain-containing protein 2 restrains cancer stem cell properties in esophageal squamous cell carcinoma via blockade of the Hedgehog signaling pathway.
    Li N; Yu Y; Wang B
    Am J Physiol Cell Physiol; 2020 Jul; 319(1):C93-C104. PubMed ID: 31747529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
    Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA LINC00675 inhibits tumorigenesis and EMT via repressing Wnt/β-catenin signaling in esophageal squamous cell carcinoma.
    Zhong YB; Shan AJ; Lv W; Wang J; Xu JZ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8288-8297. PubMed ID: 30556869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and functional regulation of stemness gene Lgr5 in esophageal squamous cell carcinoma.
    Lv Z; Yu JJ; Zhang WJ; Xiong L; Wang F; Li LF; Zhou XL; Gao XY; Ding XF; Han L; Cai YF; Ma W; Wang LX
    Oncotarget; 2017 Apr; 8(16):26492-26504. PubMed ID: 28404917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of U three protein 14a (UTP14a) is associated with poor prognosis of esophageal squamous cell carcinoma.
    Li KK; Mao CY; Zhang JG; Ma Q; Wang YJ; Liu XH; Bao T; Guo W
    Thorac Cancer; 2019 Nov; 10(11):2071-2080. PubMed ID: 31496055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EIF3H promotes aggressiveness of esophageal squamous cell carcinoma by modulating Snail stability.
    Guo X; Zhu R; Luo A; Zhou H; Ding F; Yang H; Liu Z
    J Exp Clin Cancer Res; 2020 Aug; 39(1):175. PubMed ID: 32867821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SOX2/SALL4 stemness axis modulates Notch signaling genes to maintain self-renewal capacity of esophageal squamous cell carcinoma.
    Forghanifard MM; Kasebi P; Abbaszadegan MR
    Mol Cell Biochem; 2021 Feb; 476(2):921-929. PubMed ID: 33098486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated analysis highlights multiple long non‑coding RNAs and their potential roles in the progression of human esophageal squamous cell carcinoma.
    Li CY; Zhang WW; Xiang JL; Wang XH; Wang JL; Li J
    Oncol Rep; 2019 Dec; 42(6):2583-2599. PubMed ID: 31638253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
    Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G
    Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.